Drug points: Severe myalgia from an interaction between treatments with pantoprazole and methotrexate.
作者信息
Tröger U, Stötzel B, Martens-Lobenhoffer J, Gollnick H, Meyer F P
机构信息
Institute of Clinical Pharmacology, Hospital of the Otto-von-Guericke-University, D-39120 Magdeburg, Germany.
出版信息
BMJ. 2002 Jun 22;324(7352):1497. doi: 10.1136/bmj.324.7352.1497.
Abstract
摘要
相似文献
1
Drug points: Severe myalgia from an interaction between treatments with pantoprazole and methotrexate.
BMJ. 2002 Jun 22;324(7352):1497. doi: 10.1136/bmj.324.7352.1497.
2
Apparent anaphylaxis associated with pantoprazole.
Am J Health Syst Pharm. 2005 Jul 1;62(13):1388-9. doi: 10.2146/ajhp040375.
3
Multiple organ failure and pantoprazole.
Aust N Z J Med. 2000 Dec;30(6):730. doi: 10.1111/j.1445-5994.2000.tb04373.x.
4
Adverse reactions to pantoprazole.
Scand J Gastroenterol. 2003 Jul;38(7):800. doi: 10.1080/00365520310002797.
5
Multiple organ failure related to pantoprazole.
Aust N Z J Med. 1999 Dec;29(6):833-4. doi: 10.1111/j.1445-5994.1999.tb00796.x.
6
Possible phototoxicity with subsequent progression to discoid lupus following pantoprazole administration.
Clin Exp Dermatol. 2001 Jul;26(5):455-6. doi: 10.1046/j.1365-2230.2001.00857.x.
7
Nonallergic anaphylaxis to pantoprazole.
Allergy. 2002 Feb;57(2):184. doi: 10.1034/j.1398-9995.2002.1n3496.x.
8
Elevated quetiapine serum concentrations in a patient treated concomitantly with doxepin, lorazepam, and pantoprazole.
J Clin Psychopharmacol. 2004 Oct;24(5):568-71. doi: 10.1097/01.jcp.0000139756.58092.d8.
9
Pantoprazole-induced thrombocytopenia.
Ann Pharmacother. 2006 Apr;40(4):758-61. doi: 10.1345/aph.1G384. Epub 2006 Mar 28.
10
[Mastopathy after estradiol and pantoprazol treatment].
Aten Primaria. 2003 Oct 31;32(7):435. doi: 10.1016/s0212-6567(03)70765-3.
引用本文的文献
1
Pancytopenia Due to Possible Drug-Drug Interactions Between Low-Dose Methotrexate and Proton Pump Inhibitors.
Drug Healthc Patient Saf. 2022 May 17;14:75-78. doi: 10.2147/DHPS.S350194. eCollection 2022.
2
Proton Pump Inhibitors and Oncologic Treatment Efficacy: A Practical Review of the Literature for Oncologists.
Curr Oncol. 2021 Feb 3;28(1):783-799. doi: 10.3390/curroncol28010076.
3
Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance.
Oncologist. 2018 Jan;23(1):52-61. doi: 10.1634/theoncologist.2017-0243. Epub 2017 Oct 27.
4
Retrospective evaluation of methotrexate elimination when co-administered with proton pump inhibitors.
Br J Clin Pharmacol. 2014 Sep;78(3):565-71. doi: 10.1111/bcp.12384.
5
Accumulating evidence for a drug-drug interaction between methotrexate and proton pump inhibitors.
Oncologist. 2012;17(4):550-4. doi: 10.1634/theoncologist.2011-0431. Epub 2012 Apr 3.
6
Potential drug-drug interactions between anti-cancer agents and community pharmacy dispensed drugs.
Pharm World Sci. 2010 Oct;32(5):575-80. doi: 10.1007/s11096-010-9410-0. Epub 2010 Jul 20.
7
Pharmacokinetic drug interaction profiles of proton pump inhibitors.
Drug Saf. 2006;29(9):769-84. doi: 10.2165/00002018-200629090-00002.
8
Determinants of the elimination of methotrexate and 7-hydroxy-methotrexate following high-dose infusional therapy to cancer patients.
Br J Clin Pharmacol. 2006 Jul;62(1):71-80. doi: 10.1111/j.1365-2125.2005.02513.x.
9
Role of the breast cancer resistance protein (ABCG2) in drug transport.
AAPS J. 2005 May 11;7(1):E118-33. doi: 10.1208/aapsj070112.
10
Clinical pharmacology of proton pump inhibitors: what the practising physician needs to know.
Drugs. 2003;63(24):2739-54. doi: 10.2165/00003495-200363240-00004.
本文引用的文献
1
Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity.
Semin Arthritis Rheum. 1998 Apr;27(5):277-92. doi: 10.1016/s0049-0172(98)80049-8.
2
The remarkable spectrum of methotrexate toxicities.
Rheum Dis Clin North Am. 1997 Nov;23(4):939-54. doi: 10.1016/s0889-857x(05)70367-7.
3
Interruption of long-term methotrexate treatment in psoriasis. Evaluation of clinical course and laboratory parameters after discontinuation and reintroduction of weekly oral methotrexate.
Acta Derm Venereol. 1995 Sep;75(5):393-6. doi: 10.2340/0001555575393396.
4
Underrecognized postdosing reactions to methotrexate in patients with rheumatoid arthritis.
J Rheumatol. 1994 Jul;21(7):1224-6.
5
Trace analysis of methotrexate and 7-hydroxymethotrexate in human plasma and urine by a novel high-performance liquid chromatographic method.
Ther Drug Monit. 1991 Nov;13(6):528-32. doi: 10.1097/00007691-199111000-00011.
Zotero 插件